NASDAQ : PRME
Prime Medicine, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 5.24 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 932.22M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Prime Medicine, Inc. (PRME) reported revenue of 4.07M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 4.07M | 4.63M | 2.98M | |||
| Cost of Revenue | 146.20M | 160.64M | 155.29M | 147.91M | 86.72M | 70.55M |
| Gross Profit | -142.13M | -156.00M | -152.31M | -147.91M | -86.72M | -70.55M |
| Selling, General & Admin | 54.39M | 52.35M | 50.16M | 43.39M | 29.82M | 13.92M |
| Operating Expenses | 54.39M | 52.35M | 50.16M | 43.39M | 29.82M | 13.92M |
| Operating Income | -196.52M | -208.35M | -202.47M | -191.29M | -116.54M | -84.47M |
| Interest & Investment Income | 4.03M | 4.15M | 3.52M | 2.81M | ||
| Other Non Operating Income (Expenses) | 199.00K | 148.00K | 41.00K | 274.00K | 1.90M | -80.99M |
| EBT Excluding Unusual Items | -192.29M | -204.05M | -198.90M | -188.21M | -114.64M | -165.46M |
| Gain (Loss) on Sale of Investments | 4.40M | 2.91M | 3.02M | 3.29M | -8.13M | -391.00K |
| Other Unusual Items | -13.50M | |||||
| Pretax Income | -187.89M | -201.14M | -195.88M | -198.41M | -122.77M | -165.85M |
| Income Tax Expense | -279.00K | -948.00K | -486.00K | |||
| Net Income | -187.89M | -201.14M | -195.88M | -198.13M | -121.82M | -165.37M |
| Preferred Dividends & Other Adjustments | 20.19M | 18.75M | ||||
| Net Income to Common | -187.89M | -201.14M | -195.88M | -198.13M | -142.01M | -184.12M |
| Shares Outstanding (Basic) | 173.12M | 148.76M | 118.60M | 90.97M | 33.89M | 12.97M |
| Shares Outstanding (Diluted) | 173.12M | 148.76M | 118.60M | 90.97M | 33.89M | 12.97M |
| EPS (Basic) | -1.09 | -1.35 | -1.65 | -2.18 | -4.19 | -14.19 |
| EPS (Diluted) | -1.09 | -1.35 | -1.65 | -2.18 | -4.19 | -14.19 |
| Free Cash Flow | -156.85M | -167.09M | -130.16M | -174.14M | -147.92M | -38.23M |
| Free Cash Flow Per Share | -0.91 | -1.12 | -1.10 | -1.91 | -4.37 | -2.95 |
| Operating Margin | -4,824.95% | -4,498.06% | -6,787.36% | |||
| Profit Margin | -4,613.11% | -4,342.44% | -6,566.61% | |||
| Free Cash Flow Margin | -3,850.92% | -3,607.40% | -4,363.36% | |||
| EBITDA | -189.12M | -201.03M | -196.34M | -186.64M | -114.32M | -83.91M |
| D&A For EBITDA | 7.40M | 7.32M | 6.13M | 4.65M | 2.22M | 568.00K |
| EBIT | -196.52M | -208.35M | -202.47M | -191.29M | -116.54M | -84.47M |
| Revenue as Reported | 4.63M | 4.63M | 2.98M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 47.45M | 63.03M | 182.48M | 41.57M | 187.62M | 185.42M |
| Short-Term Investments | 47.62M | 114.65M | 7.97M | 80.09M | 106.30M | 84.20M |
| Cash & Short-Term Investments | 95.07M | 177.68M | 190.44M | 121.67M | 293.92M | 269.62M |
| Prepaid Expenses | 1.36M | 2.94M | 6.78M | 19.06M | 2.45M | 959.00K |
| Other Current Assets | 376.00K | 674.00K | 14.67M | 2.25M | 246.00K | |
| Total Current Assets | 96.80M | 181.29M | 211.89M | 142.98M | 296.62M | 270.58M |
| Property, Plant & Equipment | 137.54M | 146.75M | 71.56M | 36.60M | 48.55M | 15.68M |
| Other Long-Term Assets | 14.69M | 14.69M | 14.06M | 14.28M | 15.14M | 15.60M |
| Total Assets | 249.04M | 342.73M | 297.51M | 193.85M | 360.31M | 301.86M |
| Accounts Payable | 5.81M | 8.89M | 11.35M | 19.54M | 4.33M | 1.44M |
| Accrued Expenses | 8.06M | 10.90M | 11.82M | 10.23M | 9.02M | 36.19M |
| Current Portion of Leases | 8.97M | 8.14M | 3.61M | 9.28M | 11.69M | 7.34M |
| Current Unearned Revenue | 7.93M | 7.82M | 7.09M | |||
| Other Current Liabilities | 916.00K | 1.70M | 4.08M | 17.38M | 1.67M | 13.02M |
| Total Current Liabilities | 31.69M | 37.45M | 37.96M | 56.42M | 26.71M | 57.98M |
| Long-Term Leases | 103.51M | 108.29M | 37.18M | 4.36M | 17.05M | 3.07M |
| Long-Term Unearned Revenue | 56.03M | 58.13M | 63.22M | |||
| Long-Term Deferred Tax Liabilities | 279.00K | 1.24M | ||||
| Other Long-Term Liabilities | 18.00M | 18.00M | 6.00M | |||
| Total Liabilities | 209.23M | 221.87M | 144.36M | 60.78M | 44.04M | 62.30M |
| Common Stock | 2.00K | 2.00K | 2.00K | 2.00K | 2.00K | |
| Additional Paid-In Capital | 1.02B | 1.01B | 840.36M | 624.41M | 609.85M | 15.16M |
| Retained Earnings | -979.59M | -888.35M | -687.21M | -491.33M | -293.20M | -171.38M |
| Comprehensive Income & Other | -9.00K | 82.00K | 1.00K | -15.00K | -384.00K | -27.00K |
| Total Common Equity | 39.81M | 120.87M | 153.15M | 133.07M | 316.27M | -156.24M |
| Shareholders' Equity | 39.81M | 120.87M | 153.15M | 133.07M | 316.27M | 239.56M |
| Total Liabilities & Equity | 249.04M | 342.73M | 297.51M | 193.85M | 360.31M | 301.86M |
| Total Debt | 112.48M | 116.43M | 40.79M | 13.63M | 28.75M | 10.41M |
| Net Cash (Debt) | -17.41M | 61.25M | 149.65M | 108.03M | 265.18M | 259.21M |
| Net Cash Per Share | -0.10 | 0.41 | 1.26 | 1.19 | 7.82 | 19.98 |
| Filing Date Shares Outstanding | 177.90M | 177.08M | 127.66M | 115.20M | 88.40M | 17.06M |
| Total Common Shares Outstanding | 177.27M | 177.04M | 127.66M | 92.64M | 88.36M | 17.06M |
| Working Capital | 65.11M | 143.84M | 173.93M | 86.55M | 269.90M | 212.60M |
| Book Value Per Share | 0.22 | 0.68 | 1.20 | 1.44 | 3.58 | -9.16 |
| Tangible Book Value | 39.81M | 120.87M | 153.15M | 133.07M | 316.27M | -156.24M |
| Tangible Book Value Per Share | 0.22 | 0.68 | 1.20 | 1.44 | 3.58 | -9.16 |
| Machinery | 33.19M | 32.73M | 29.29M | 24.16M | 19.67M | 5.42M |
| Construction In Progress | 47.00K | 365.00K | 3.58M | 5.40M | 1.61M | |
| Leasehold Improvements | 7.91M | 7.91M | 5.14M | 579.00K | 564.00K | 125.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -187.89M | -201.14M | -195.88M | -198.13M | -121.82M | -165.37M |
| Depreciation & Amortization | 7.40M | 7.32M | 6.13M | 4.65M | 2.22M | 568.00K |
| Loss (Gain) From Sale of Assets | 28.00K | 8.00K | ||||
| Asset Writedown & Restructuring Costs | 12.02M | |||||
| Loss (Gain) From Sale of Investments | -4.10M | -2.37M | -2.61M | -1.03M | 7.88M | 1.11M |
| Stock-Based Compensation | 26.77M | 29.27M | 26.07M | 13.91M | 6.46M | 1.75M |
| Other Operating Activities | 10.65M | 9.70M | 12.36M | 12.51M | 8.83M | 84.67M |
| Change in Accounts Payable | -509.00K | 996.00K | -5.26M | 9.14M | 2.46M | 1.19M |
| Change in Unearned Revenue | -3.91M | -4.36M | 70.31M | |||
| Change in Other Net Operating Assets | -4.46M | -1.98M | -33.98M | -6.49M | -37.86M | 29.99M |
| Operating Cash Flow | -156.05M | -162.56M | -122.86M | -165.41M | -131.83M | -34.08M |
| Capital Expenditures | -797.00K | -4.53M | -7.29M | -8.72M | -16.09M | -4.15M |
| Investment in Securities | 4.43M | -104.23M | 74.75M | 27.61M | -30.34M | -68.98M |
| Other Investing Activities | 1.00M | -170.00K | -665.00K | -496.00K | ||
| Investing Cash Flow | 3.63M | -108.76M | 68.46M | 18.71M | -47.10M | -73.63M |
| Issuance of Common Stock | 140.07M | 139.51M | 171.08M | 655.00K | 185.54M | |
| Other Financing Activities | 6.00M | 12.00M | 24.80M | -4.04M | -1.09M | |
| Financing Cash Flow | 146.07M | 151.51M | 195.88M | 655.00K | 181.49M | 269.28M |
| Net Cash Flow | -6.35M | -119.81M | 141.47M | -146.05M | 2.57M | 161.57M |
| Free Cash Flow | -156.85M | -167.09M | -130.16M | -174.14M | -147.92M | -38.23M |
| Free Cash Flow Margin | -3,850.92% | -3,607.40% | -4,363.36% | |||
| Free Cash Flow Per Share | -0.91 | -1.12 | -1.10 | -1.91 | -4.37 | -2.95 |
| Levered Free Cash Flow | -75.78M | -85.37M | -114.57M | -96.21M | -117.62M | -6.80M |
| Unlevered Free Cash Flow | -75.78M | -85.37M | -114.57M | -96.21M | -117.62M | -6.80M |
| Change in Working Capital | -8.88M | -5.34M | 31.08M | 2.65M | -35.40M | 31.18M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 839.71M | 614.32M | 372.58M | 817.15M | 1.61B | |
| Enterprise Value | 857.12M | 519.17M | 238.30M | 668.88M | 1.89B | |
| Last Close Price | 4.72 | 3.47 | 2.92 | 8.86 | 18.58 | |
| PS Ratio | 206.16 | 132.63 | 124.90 | |||
| PB Ratio | 21.02 | 5.08 | 2.43 | 6.14 | 5.09 | |
| P/TBV Ratio | 21.09 | 5.08 | 2.43 | 6.14 | 5.09 | |
| EV/Sales Ratio | 210.44 | 112.08 | 79.89 | |||
| Debt / Equity Ratio | 2.83 | 0.96 | 0.27 | 0.10 | 0.09 | 0.04 |
| Net Debt / Equity Ratio | 0.44 | -0.51 | -0.98 | -0.81 | -0.84 | -1.08 |
| Net Debt / EBITDA Ratio | -0.09 | 0.30 | 0.76 | 0.58 | 2.32 | 3.09 |
| Net Debt / FCF Ratio | -0.11 | 0.37 | 1.15 | 0.62 | 1.79 | 6.78 |
| Asset Turnover | 0.01 | 0.01 | 0.01 | |||
| Quick Ratio | 3.00 | 4.75 | 5.02 | 2.16 | 11.00 | 4.65 |
| Current Ratio | 3.06 | 4.84 | 5.58 | 2.53 | 11.10 | 4.67 |
| Return on Equity (ROE) | -373.29% | -146.81% | -136.88% | -88.19% | -43.83% | -121.13% |
| Return on Assets (ROA) | -46.52% | -40.68% | -51.51% | -43.15% | -22.00% | -29.61% |
| Return on Capital Employed (ROCE) | -90.40% | -68.20% | -78.00% | -139.20% | -34.90% | -34.60% |
| Earnings Yield | -22.99% | -32.74% | -52.58% | -24.25% | -7.57% | |
| FCF Yield | -18.68% | -27.20% | -34.94% | -21.31% | -9.19% | |
| Buyback Yield / Dilution | -36.41% | -25.43% | -30.37% | -168.41% | -161.23% | -391.47% |